» Articles » PMID: 30142934

Exogenous Heat Shock Cognate Protein 70 Suppresses LPS-Induced Inflammation by Down-Regulating NF-κB Through MAPK and MMP-2/-9 Pathways in Macrophages

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2018 Aug 26
PMID 30142934
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Heat shock cognate protein 70 (HSC70), a molecular chaperone, is constitutively expressed by mammalian cells to regulate various cellular functions. It is associated with many diseases and is a potential therapeutic target. Although HSC70 also possesses an anti-inflammatory action, the mechanism of this action remains unclear. This current study aimed to assess the anti-inflammatory effects of HSC70 in murine macrophages RAW 264.7 exposed to lipopolysaccharides (LPS) and to explain its pathways. Mouse macrophages (RAW 264.7) in 0.1 µg/mL LPS incubation were pretreated with recombinant HSC70 (rHSC70) and different assays (Griess assay, enzyme-linked immune assay/ELISA, electrophoretic mobility shift assay/EMSA, gelatin zymography, and Western blotting) were performed to determine whether rHSC70 blocks pro-inflammatory mediators. The findings showed that rHSC70 attenuated the nitric oxide (NO) generation, tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) expressions in LPS-stimulated RAW264.7 cells. In addition, rHSC70 preconditioning suppressed the activities and expressions of matrix metalloproteinase-2 (MMP-2) and MMP-9. Finally, rHSC70 diminished the nuclear translocation of nuclear factor-κB (NF-κB) and reduced the phosphorylation of extracellular-signal regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinases (MAPK), and phosphatidylinositol-3-kinase (PI3K/Akt). We demonstrate that rHSC70 preconditioning exerts its anti-inflammatory effects through NO production constriction; TNF-α, and IL-6 suppression following down-regulation of inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2), and MMP-2/MMP-9. Accordingly, it ameliorated the signal transduction of MAPKs, Akt/IκBα, and NF-κB pathways. Therefore, extracellular HSC70 plays a critical role in the innate immunity modulation and mechanisms of endogenous protective stimulation.

Citing Articles

Anti-Inflammatory Effects of Extracellular Vesicles from on 12-O-Tetradecanoylphorbol-13-Acetate-Induced Skin Inflammation in Mice.

Kim G, Lee S, Oh S, Jang J, Lee J, Kim H Int J Mol Sci. 2024; 25(23).

PMID: 39684233 PMC: 11641720. DOI: 10.3390/ijms252312522.


Extracellular Vesicles from and Phlorotannin Promote Rejuvenation in Aged Skin.

Batsukh S, Oh S, Lee J, Joo J, Son K, Byun K Mar Drugs. 2024; 22(5).

PMID: 38786614 PMC: 11123375. DOI: 10.3390/md22050223.


Heat shock protein 70 protects the lungs from hyperoxic injury in a neonatal rat model of bronchopulmonary dysplasia.

Lee C, Su T, Lee M, Hsu C, Yang R, Kao J PLoS One. 2023; 18(5):e0285944.

PMID: 37200358 PMC: 10194897. DOI: 10.1371/journal.pone.0285944.


SILAC-based quantitative proteomics to investigate the eicosanoid associated inflammatory response in activated macrophages.

Brace N, Megson I, Rossi A, Doherty M, Whitfield P J Inflamm (Lond). 2022; 19(1):12.

PMID: 36050729 PMC: 9438320. DOI: 10.1186/s12950-022-00309-8.


RPS4XL encoded by lnc-Rps4l inhibits hypoxia-induced pyroptosis by binding HSC70 glycosylation site.

Li Y, Zhang J, Sun H, Yu X, Chen Y, Ma C Mol Ther Nucleic Acids. 2022; 28:920-934.

PMID: 35757299 PMC: 9185019. DOI: 10.1016/j.omtn.2022.05.033.


References
1.
Morita I . Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 2002; 68-69:165-75. DOI: 10.1016/s0090-6980(02)00029-1. View

2.
Aneja R, Odoms K, Dunsmore K, Shanley T, Wong H . Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J Immunol. 2006; 177(10):7184-92. DOI: 10.4049/jimmunol.177.10.7184. View

3.
Yeh J, Hsu J, Liang J, Chen I, Liou S . Lercanidipine and labedipinedilol--A attenuate lipopolysaccharide/interferon-γ-induced inflammation in rat vascular smooth muscle cells through inhibition of HMGB1 release and MMP-2, 9 activities. Atherosclerosis. 2013; 226(2):364-72. DOI: 10.1016/j.atherosclerosis.2012.12.005. View

4.
Lopez A, Lorente J, Steingrub J, Bakker J, McLuckie A, Willatts S . Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med. 2004; 32(1):21-30. DOI: 10.1097/01.CCM.0000105581.01815.C6. View

5.
Schefold J, Hasper D, Volk H, Reinke P . Sepsis: time has come to focus on the later stages. Med Hypotheses. 2008; 71(2):203-8. DOI: 10.1016/j.mehy.2008.03.022. View